SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is facing a massive sell-off as a weak revenue outlook and significant declines in the China market overshadow an earnings beat, fueling intense debate over whether this decade-long low represents a generational buying opportunity or a deeper structural decline. The community is sharply divided, with many traders betting on a sharp V-shaped recovery and a "juicy" dividend, while skeptics argue that the brand's long-term growth is dead and are cautioning against catching a falling knife.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is trending amid intense community debate over its aggressive Bitcoin-linked treasury strategy, with investors highlighting significant price volatility and concerns regarding share dilution. The conversation is currently split between those betting on long-term institutional adoption and short sellers pointing to structural leverage risks and downward price action.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiserv is trending as investors react to a series of analyst downgrades, a recent activist stake from Jana Partners, and a disconnect between the company's strong cash flow and its depressed valuation. While some retail investors are calling it a value trap due to stagnant performance, others are actively buying the dip, citing its dominant market position and low forward P/E as evidence of a significant buying opportunity.

Wingstop, Inc. is a franchisor and chicken wings-focused restaurant. The firm is engaged in the flavor business offering cooked-to-order, hand-sauced, and tossed classic and boneless wings, tenders and chicken sandwiches in flavors, with signature sides, such as its seasoned fries and house made ranch and bleu cheese dips. The company was founded in 1994 and is headquartered in Dallas, TX.

Wingstop Inc

Wingstop is experiencing intense volatility and downward pressure as investors debate whether the stock is an oversold growth opportunity or a bubble facing a severe consumer discretionary correction. While bullish participants point to the company's aggressive store expansion, share buybacks, and international potential as reasons to buy the dip, bears are aggressively shorting the stock, citing concerns over same-store sales declines, high valuations, and broader fears of consumer exhaustion impacting the restaurant sector.

RH operates as a holding company which operates the business through its subsidiary Restoration Hardware, Inc. It offers furniture, lighting, textiles, bath ware, decor, outdoor and garden, as well as baby and child products. The company operates an integrated business with multiple channels of distribution including galleries, source books and websites. The company was founded by Stephen J. Gordon in 1980 and is headquartered in Corte Madera, CA.

RH - Ordinary Shares - Class A

Restoration Hardware

Restoration Hardware is trending due to significant volatility following a quarterly earnings report that featured a revenue beat but a notable miss on earnings expectations, coupled with cautious guidance linked to ongoing tariff pressures and housing market headwinds. Investors are actively debating the stock's future, weighing concerns over debt and luxury spending against potential upside from long-term global expansion and anticipation of favorable legal outcomes regarding trade tariffs.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience is experiencing intense volatility and social media attention as traders monitor its low-float structure and history of sharp, squeeze-driven price moves. The community is actively debating whether current price action signals a repeat of past parabolic runs, with many focusing on the high cost to borrow, limited share availability, and the potential for a swift short squeeze.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

The S&P 500 is experiencing heightened volatility as market participants weigh conflicting reports regarding geopolitical tensions in the Middle East and anticipated commentary from political leadership. Investors are actively debating whether recent gains represent a durable recovery or a bull trap, with many closely monitoring crude oil fluctuations and potential impacts on global trade as they hedge against significant uncertainty ahead of scheduled policy speeches.

Alexandria Real Estate Equities, Inc. engages in the provision of space for lease. It offers properties for rent to life science, agriculture technology (agtech), and technology tenants. The company was founded by Alan D. Gold, Gary A. Kreitzer, Joel S. Marcus, and Jerry M. Sudarsky in October 1994 and is headquartered in Pasadena, CA.

Alexandria Real Estate Equities Inc.

Alexandria Real Estate is currently drawing significant investor scrutiny as share prices hover near multi-year lows, triggering a divide between those concerned by high debt levels and structural biotech sector headwinds, and contrarian investors who view the current valuation as an extreme dislocation from the company's underlying property portfolio value. The community is actively debating the sustainability of the dividend and monitoring institutional accumulation patterns, with many participants treating the current price action as a deeply oversold opportunity despite the near-term uncertainty.

Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.

ORIC Pharmaceuticals Inc

ORIC Pharmaceuticals is trending following a significant clinical update regarding its Phase 1b trial of rinzimetostat in combination with darolutamide for prostate cancer. While the stock faced an intraday slump due to concerns over safety signals at higher doses, community discussion remains heavily divided between those viewing the selloff as an exaggerated overreaction with upside potential and those concerned about the broader implications for EZH2-targeting drug classes.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is currently facing intense selling pressure driven by a mix of weak quarterly earnings, concerns regarding equity dilution, and a class-action lawsuit alleging misleading disclosures about project partnerships. Despite this negative sentiment and short-term volatility, the community remains divided, with long-term investors pointing to the growing demand for nuclear energy in AI data centers as a reason to accumulate shares while traders monitor critical support levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aytu BioPharma Inc. (AYTU) Reports Q2 Loss, Beats Revenue Estimates

Aytu BioPharma (AYTU) delivered earnings and revenue surprises of -303.85% and +26.27%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Aytu BioPharma AYTU Q2 2026 Earnings Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

New Strong Sell Stocks for February 2nd

AAWH, AYTU and BCAL have been added to the Zacks Rank #5 (Strong Sell) List on February 2, 2026.

Aytu BioPharma Inc. (AYTU) Reports Q1 Loss, Tops Revenue Estimates

Aytu BioPharma (AYTU) delivered earnings and revenue surprises of -33.33% and +10.05%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Insights into Aytu BioPharma's Upcoming Earnings

Astria Therapeutics, Inc. (ATXS) Reports Q3 Loss, Misses Revenue Estimates

Astria Therapeutics (ATXS) delivered earnings and revenue surprises of -34.15% and -95.59%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates

Eton Pharmaceuticals (ETON) delivered earnings and revenue surprises of -153.85% and +9.24%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

New Strong Sell Stocks for Oct. 13th

AYTU, ALK and CNM have been added to the Zacks Rank #5 (Strong Sell) List on October 13, 2025.

U.S. stocks appear set for a positive opening on Tuesday ahead of Federal Reserve Chair Jerome Powell’s speech as investors look for clues on the central bank’s direction on monetary policy going forward.While Dow Jones futures were up 0.13% at the time of writing, the S&amp;P 500 futures edged lower by 0.03%, while the tech-heavy Nasdaq 100’s futures rose 0.02%. Futures of the Russell 2000 index were up 0.04%.Meanwhile, the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY) was down 0.03% at the time of writing, while&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ) rose 0.02% on Tuesday morning. Retail sentiment around the S&amp;P 500 ETF on Stocktwits was in the ‘bullish’ territory.Asian markets ended Tuesday’s trading session on a mixed note, with the TWSE Capitalization Weighted Stock index gaining the most at 1.4%, followed by the KOSPI at 0.5%.The Shanghai Composite index declined 0.9%, while the Hang Seng index closed lower by 0.54%.The Nikkei 225 index was closed for trading due to the Autumnal Equinox.Stocks To Watch<ul><li>Boeing Co. (BA): Boeing shares were up nearly 3% in Tuesday’s pre-market session amid reports that the U.S. and China are in the final stages of negotiation for a “huge” deal for the company’s aircraft, according to a Bloomberg&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-09-23/us-china-talks-for-huge-boeing-aircraft-order-in-final-stages">report</a>.</li><li>MicroCloud Hologram Inc. (HOLO): MicroCloud shares continued to soar following an&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/micro-cloud-hologram-stock-picks-up-momentum-after-near-wipeout-this-year/chDhN2vR3PS">announcement</a> by the company on Friday last week that it has developed a universal quantum probability theory to control the phase of quantum photonic states, which has applications across multiple domains. MicroCloud was the top trending ticker on the Stocktwits platform at the time of writing, with the stock up more than 20% in Tuesday’s pre-market session.</li><li>Better Home &amp; Finance Holding Co. (BETR): Better Home’s shares were up nearly 25% in Tuesday’s pre-market trade after hedge fund manager Eric Jackson&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/better-stock-rockets-as-opendoor-bull-eric-jackson-predicts-350x-gains/chDhKvgR3PI">disclosed</a> a position in the company on Monday.</li><li>Firefly Aerospace Inc. (FLY): Firefly Aerospace shares plunged nearly 10% pre-market after the company’s second-quarter (Q2) results missed Wall Street expectations. Firefly reported a loss of $5.78 per share on revenue of $15.55 million, while analysts expected a loss of $0.43 per share on revenue of $16.82 million, according to Stocktwits data.</li><li>CleanSpark Inc. (CLSK): CleanSpark shares surged more than 5% in Tuesday’s pre-market session after the Bitcoin mining company&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-cleanspark-stock-rising-5-premarket/chDhoueR3Ps">secured</a> a new $100 million credit facility with Coinbase Prime.</li><li>Micron Technology Inc. (MU) and Aytu BioPharma Inc. (AYTU) are among the companies scheduled to announce their latest quarterly results on Tuesday.</li></ul>&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/fed-musalem-limited-room-for-further-rate-cuts/chDQqpnR321">Fed's Musalem Says There's 'Limited Room' For Further Rate Cuts Without Policy Becoming Overly Accommodative</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

People walk by the New York Stock Exchange

Dow Futures Gain Ahead Of Jerome Powell’s Speech: BA, HOLO, BETR, CLSK Among Stocks To Watch

While Dow Jones futures were up 0.13% at the time of writing, the S&P 500 futures edged lower by 0.03%.

Equity

Agilent Technologies (A) Surpasses Q3 Earnings and Revenue Estimates

Agilent (A) delivered earnings and revenue surprises of +0.74% and +4.60%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?

Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR, and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Denver, CO.

Aytu BioPharma Inc

Thematic ETFs

Prediction Markets

OpenClaw & Agentic-Directed Trading

Tokenization

Recognizing the tool or mechanism that redefined how we trade. From prediction markets to next-gen tech, this award honors the innovation that pushed the boundaries of access and efficiency in modern finance.

Current Price	$2.68
Prev Close	$2.73
Open	$2.73
Dividend Yield	0.00%
50-Day Moving Average	$2.52
Beta	0.86
Avg. Volume	61,424.24
PE Ratio	-0.71

52-Week High	$3.07
52-Week Low	$0.95
Market Capitalization	$29.3M
EPS (Annual)	-$2.16
Price to Book	2.06
Revenue Per Employee	$799,783.13

AYTU
Aytu BioPharma Inc

Feed

News

Sentiment

Fundamentals

Info

Latest AYTU News

AYTUAytu BioPharma Inc